Call for applications: Continuous Patient Education (CoPE) new call opens

21/12

We are pleased to announce that a call for applications for CoPE is now open. Please find below detailed information on…

The EATG publishes its position paper on sex work policy

17/12

Today, on the occasion of the International Day to End Violence Against Sex Workers, the European AIDS Treatment Group publishes…

Vieillir avec le VIH: Brussels-based organisations met to discuss about ageing with HIV

14/12

This week the European AIDS Treatment Group participated in a meeting on “Ageing with HIV: What challenges? What ways forward?”,…

Combination therapy found to be more effective in treating patients with leishmaniasis and HIV

17/01

The results of clinical trials conducted in Ethiopia by the Drugs for Neglected Diseases initiative (DNDi), in partnership with Médecins Sans Frontières…

Efavirenz in pregnancy is at least as safe as other antiretrovirals

17/01

No safety signal for raltegravir either An individual patient data analysis of almost 25,000 pregnancies in women living with HIV…

ECDC: Hepatitis A – Annual epidemiological report for 2016

17/01

The European Centre for Disease Prevention and Control (ECDC) released the Hepatitis A – Annual epidemiological report for 2016. The…

Call for applications: Continuous Patient Education (CoPE) new call opens

21/12

We are pleased to announce that a call for applications for CoPE is now open. Please find below detailed information on…

The EATG publishes its position paper on sex work policy

17/12

Today, on the occasion of the International Day to End Violence Against Sex Workers, the European AIDS Treatment Group publishes…

Vieillir avec le VIH: Brussels-based organisations met to discuss about ageing with HIV

14/12

This week the European AIDS Treatment Group participated in a meeting on “Ageing with HIV: What challenges? What ways forward?”,…

Combination therapy found to be more effective in treating patients with leishmaniasis and HIV

17/01

The results of clinical trials conducted in Ethiopia by the Drugs for Neglected Diseases initiative (DNDi), in partnership with Médecins Sans Frontières…

Efavirenz in pregnancy is at least as safe as other antiretrovirals

17/01

No safety signal for raltegravir either An individual patient data analysis of almost 25,000 pregnancies in women living with HIV…

ECDC: Hepatitis A – Annual epidemiological report for 2016

17/01

The European Centre for Disease Prevention and Control (ECDC) released the Hepatitis A – Annual epidemiological report for 2016. The…